CV – capsovision, inc. (US:NASDAQ)

News

CapsoVision (CV) had its price target lowered by Benchmark Co. from $14.00 to $10.00. They now have a "speculative buy" rating on the stock.
CapsoVision Q4 Earnings Call Highlights [Yahoo! Finance]
CapsoVision, Inc. reports Q4 results [Seeking Alpha]
CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results
CapsoVision Conference: CEO Maps AI-Driven Capsule Endoscopy Roadmap for Colon and Pancreas Screening [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com